4-Methyl-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine, 95%, 1g

5-Cyanothiophene-2-boronic acid, 97.0%, 1g

1-Methyl-1,4-diazepan-2-one hydrochloride, 95.0%, 250mg

Methyl 4-((trimethylsilyl)ethynyl)benzoate, 95.0%, 250mg

(4-(P-tolyloxy)phenyl)methanamine, 95%, 100mg

Tert-butyl (S)-(1-cyano-2-methylpropyl)carbamate, 95+%, 5g

3-Phenylisothiazol-5-amine, 95.0%, 10g

Tripropylene glycol monobutyl ether, min 95%, for synthesis, 2.5 l, plastic packaging.

2-(Difluoromethoxy)benzylamine, 97.0%, 5g

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2,3-DIHYDRO-1H-INDEN-2-OL, 95%, 50mg

5,6-Dichloro-N-(2,4-dimethoxybenzyl)-N-(thiazol-2-yl)pyridine-3-sulfonamide, 95%, 50mg

O-(3,4-dichlorobenzyl)hydroxylamine hydrochloride, 95+%, 1g

2-Bromo-5-hydroxy-4-methoxybenzaldehyde, 95.0%, 500g